Antibiotics exposure and risk of inflammatory bowel disease: a systematic review

References

• Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185–1191.
   PubMed Web of Science ®Google Scholar
• Zhulina Y, Udumyan R, Tysk C, et al. The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963–2005. Scand J Gastroenterol. 2016;51:304–313.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. New insights into IBD epidemiology: are there any lessons for treatment? Dig Dis. 2010;28:406–410.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. Why and where to look in the environment with regard to the etiology of inflammatory bowel disease. Dig Dis. 2012;30(Suppl 3):28–32.
   PubMed Web of Science ®Google Scholar
• Van Kruiningen HJ, Joossens M, Vermeire S, et al. Environmental factors in familial Crohn's disease in Belgium. Inflamm Bowel Dis. 2005;11:360–365.
   PubMed Web of Science ®Google Scholar
• Sakran JV, Mylonas KS, Gryparis A, et al. Operation versus antibiotics-The “appendicitis conundrum” continues: a meta-analysis. J Trauma Acute Care Surg. 2017;82:1129–1137.
   PubMed Web of Science ®Google Scholar
• Bendtsen KM, Fisker L, Hansen AK, et al. The influence of the young microbiome on inflammatory diseases-Lessons from animal studies. Birth Defects Res C Embryo Today. 2015;105:278–295.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. Antibiotics, probiotics and prebiotics in IBD. Nestle Nutr Inst Workshop Ser. 2014;79:83–100.
   PubMedGoogle Scholar
• Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109:1728–1738.
   PubMed Web of Science ®Google Scholar
• Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci. 1994;39:555–560.
   PubMed Web of Science ®Google Scholar
• Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis. 2012;6:324–329.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Bae JM. “A suggestion for quality assessment in systematic reviews of observational studies in nutritional epidemiology”. Epidemiol Health. 2016;38:e2016014.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Richardson AK, Frampton CM, et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325–333.
   PubMed Web of Science ®Google Scholar
• Han DY, Fraser AG, Dryland P, et al. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn’s disease within New Zealand. Mutat Res. 2010;690:116–122.
   PubMed Web of Science ®Google Scholar
• Kronman MP, Zaoutis TE, Haynes K, et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics. 2012;130:e794–e803.
   PubMed Web of Science ®Google Scholar
• Li WQ, Cho E, Khalili H, et al. Rosacea, use of tetracycline, and risk of incident inflammatory bowel disease in women. Clin Gastroenterol Hepatol. 2016;14:220–223.
   PubMed Web of Science ®Google Scholar
• Margolis DJ, Fanelli M, Hoffstad O, et al. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol. 2010;105:2610–2616.
   PubMed Web of Science ®Google Scholar
• Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–1071.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687–2692.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2011;106:2133–2142.
   PubMed Web of Science ®Google Scholar
• Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn’s disease–a nationwide, register-based finnish case-control study. Am J Epidemiol. 2012;175:775–784.
   PubMed Web of Science ®Google Scholar
• Card T, Logan RFA, Rodrigues LC, et al. Antibiotic use and the development of Crohn's disease. Gut. 2004;53:246–250.
   PubMed Web of Science ®Google Scholar
• Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60:49–54.
   PubMed Web of Science ®Google Scholar
• Lee TW, Russell L, Deng M, et al. Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad. Intern Med J. 2013;43:919–926.
   PubMed Web of Science ®Google Scholar
• Niu J, Miao J, Tang Y, et al. Identification of environmental factors associated with inflammatory bowel disease in a Southwestern highland region of China: a nested case-control study. PLoS One. 2016;11:e0153524.
   PubMed Web of Science ®Google Scholar
• Perez-Cobas AE, Gosalbes MJ, Friedrichs A, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 2013;62:1591–1601.
   PubMed Web of Science ®Google Scholar
• Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111:597–603.
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci US1A. 2011;108: 4554–4561.
   PubMed Web of Science ®Google Scholar